This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Bulgaria
Why is this study shown?
This study is directly about Schizophrenia.
SchizophreniaDrugA study involving a medication or substance.
Countries
Bulgaria, Poland, Spain
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
In Bulgaria
Why is this study shown?
This study is directly about Schizophrenia.
SchizophreniaDrug
Countries
Bulgaria, Czechia, Germany, ...
Sponsor
Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda
This study is looking at whether Cognitive Behavioural Treatment versus Cognitive Remediation can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in Cognitive Behavioural Treatment versus Cognitive Remediation and complete follow-up assessments.
This study is looking at whether cognitive behavioural therapy can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in the program and complete follow-up questionnaires or assessments.
This study is looking at a support or therapy approach for people with Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in the program or support approach and complete follow-up assessments.
In United Kingdom
Why is this study shown?
This study is directly about Schizophrenia.
SchizophreniaOther
Countries
United Kingdom
Sponsor
Record Provided by the NHS R&D 'Time-Limited' National Programme Register - Department of Health (UK)
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
This study is looking at how a digital support tool works for people with Schizophrenia or Mental and Behavioural Disorders in routine care. Participants take part in a digital support tool and complete follow-up assessments.
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments.
HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.
